Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?
Yaser Pashaei
Topics & Concepts
MedicineDrug repositioningRepurposingDrugCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakPharmacologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Serotonin Uptake InhibitorsPsychiatrySerotoninVirologyInternal medicineFluoxetineInfectious disease (medical specialty)ReceptorDiseaseOutbreakBiologyEcologyTryptophan and brain disordersPharmacological Receptor Mechanisms and EffectsStress Responses and Cortisol